Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 386-387 , March 2010

Comment on Moerland et al. study of decline of dose coverage between different implant techniques for I125 prostate brachytherapy

Received 11 December 2009 ,Accepted 29 January 2010.

References 

  1. Salembier C, Lavagnini P, Nickers P, Mangili P, Rijnders A, Polo A, et al. GEC ESTRO PROBATE Group Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol. 2007;83:3–10
  2. Moerland MA, van der Laarse R, Luthmann RW, Wijrdeman HK, Battermann JJ. The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. Radiother Oncol. 2000;57:279–284
  3. Al-Qaisieh B, Carey B, Ash D, Bottomley D. The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:397–399
  4. Al-Qaisieh B, Smith DW, Brearley E, St Clair S, Bownes P. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis. Radiother Oncol. 2007;84:140–147

PII: S0167-8140(10)00072-1

doi: 10.1016/j.radonc.2010.01.020

Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 386-387 , March 2010

Article Tools